Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome — Stella

Home/Uveal Melanoma/

View on ClinicalTrials.gov

Recruiting

Back to Uveal Melanoma trials

Trial locations(1 site)

United States

The Ohio State University Wexner Medical Center, Columbus, Ohio

Key details

Sponsor

Mohamed Abdel-Rahman

Enrollment target

~500 participants

Started

March 2015

Primary completion

July 2026

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.